Cibus Q2 2026 Earnings Call Summary

1Key Financial Results and Metrics

Revenue: $1 million for the quarter, up from $900,000 year-over-year; $2.7 million for the first half, a 35% increase from $2 million in the prior year.

Cash Position: Cash and cash equivalents as of June 30, 2026, stood at $20.4 million. Quarterly cash usage declined by 19% sequentially and 31% year-over-year.

Operating Expenses: R&D expenses decreased to $8.5 million from $12.2 million year-over-year, while SG&A expenses fell to $5.4 million from $6.6 million.

Net Loss: Reported net loss of $22.1 million, improved from $26.6 million in the previous year, with a net loss per share of $0.29 compared to $0.61.

2Strategic Updates and Business Highlights

Leadership Transition: Craig Wichner joined as CEO, emphasizing a focus on revenue generation and capital discipline.

Platform Model: Cibus is leveraging its IP-protected platform to accelerate seed innovation, with a focus on sustainable ingredients and rice traits.

Commercial Progress: Significant advancements in sustainable ingredients, including biofragrance partnerships, and rice trait development with multiple customers in Latin America.

Regulatory Environment: Favorable changes in the EU and Latin America regarding gene-edited crops, which could enhance market opportunities.

3Forward Guidance and Outlook

Revenue Growth: Continued revenue generation expected from sustainable ingredients and the rice royalty business, with initial royalties anticipated to begin in 2028.

Cost Management: Targeting a net cash usage run rate of approximately $35 million by the end of 2026, while investing in technology and personnel to support growth initiatives.

Market Expansion: Plans to deepen partnerships and expand trait offerings across multiple crops, with a focus on hybrid rice in Latin America.

4Bad News, Challenges, or Points of Concern

Cash Burn: Despite a reduction in cash usage, the projected cash burn of $35 million raises concerns about long-term sustainability without additional financing.

Small Revenue Base: Current revenue figures remain low, highlighting the need for significant growth to achieve scale.

Regulatory Risks: While recent regulatory changes are favorable, ongoing compliance and potential shifts in regulations could pose risks.

5Notable Q&A Insights

Trait Partnerships: Discussion on becoming a "trait machine" for specific seed companies rather than licensing to larger conglomerates, emphasizing tailored relationships for competitive advantages.

Hybrid Rice Potential: Insights on the growing interest in hybrid rice in Latin America, with an addressable market of 5 to 7 million acres.

EU Regulatory Influence: Cibus has personnel in Europe actively engaging with regulatory bodies to influence the implementation of new legislation, which is crucial for future growth.

Sustainable Ingredients Expansion: Beyond biofragrances, Cibus is exploring other sustainable ingredient opportunities, indicating a broad platform for growth. This summary encapsulates the key points from Cibus' Q2 2026 earnings call, highlighting both the progress made and the challenges ahead as the company seeks to scale its operations and enhance its market position.